|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$979
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$1,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$18,897
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
3R01CA124644-03S1
|
$132,377
|
$132,377
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
5R01CA124644-03
|
$334,075
|
$334,075
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$1,010
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$1,489
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$47,955
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$9,995
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$7,398
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$9,898
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$646,409
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival
|
1R01CA136663-01A2
|
$340,300
|
$340,300
|
Levitskaia, Elena
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$10,002
|
$900
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
5R01CA094194-08
|
$387,333
|
$387,333
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Translational Research in Cancer
|
3P30CA056036-11S1
|
$99,766
|
$998
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-11
|
$3,102,433
|
$31,024
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Genomics of MicroRNAs in Neuroblastoma
|
5K08CA136979-02
|
$158,005
|
$158,005
|
Cole, Kristina
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Training Program in Cancer Therapeutics
|
5T32CA117846-05
|
$395,220
|
$79,044
|
WALTZ, SUSAN
|
UNIVERSITY OF CINCINNATI
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
3R01CA129831-03S1
|
$93,600
|
$30,888
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
5R01CA129831-03
|
$314,250
|
$103,703
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
|
2R01CA067938-12A2
|
$390,110
|
$390,110
|
LAHTI, JILL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
5R01CA124982-04
|
$279,300
|
$279,300
|
DING, HAN-FEI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-03
|
$667,730
|
$667,730
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Targeting Oncolytic HSV to Neuroblastoma & Malig. Peripheral Nerve Sheath Tumors
|
5F31CA132613-03
|
$33,913
|
$16,957
|
Maldonado, Arturo
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-02
|
$343,973
|
$343,973
|
Mosse, YAEL
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$92,328
|
$64,629
|
Khan, Javed
|
CCR (NCI)
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
5R01CA136912-02
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
3U24CA114766-05S1
|
$1,195,618
|
$239,124
|
Ramirez, Nilsa
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-32
|
$2,297,459
|
$505,441
|
Hendershot, Linda
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
2U10CA095968-09
|
$642,591
|
$6,426
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-20S1
|
$99,997
|
$4,000
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-20
|
$257,231
|
$10,289
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Simultaneous Tc-99m-MDP/I-123-MIBG Imaging of Neuroblastoma Using SPECT-CT
|
1R21CA140771-01A1
|
$230,985
|
$230,985
|
Ouyang, Jinsong
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$412,658
|
$41,266
|
Daar, Ira
|
CCR (NCI)
|
|
Screening of inhibitors of SIRT1 and SIRT2 for the prevention of neuroblastoma
|
1R03CA141973-01A1
|
$54,000
|
$54,000
|
Liu, Tao
|
UNIVERSITY OF NEW SOUTH WALES
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$509,039
|
$50,904
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$509,039
|
$101,808
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Hypoxia in the regulation of cancer cell differentiation
|
5R01CA125021-04
|
$314,450
|
$314,450
|
YUN, ZHONG
|
YALE UNIVERSITY
|
|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$24,000
|
N/A
|
National Cancer Institute
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$523,283
|
$313,970
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
Regulation of Apoptosis in Ewing's Sarcoma and Neuroblastoma
|
ZIA SC 010058
|
$341,777
|
$136,711
|
Tsokos, Maria
|
CCR (NCI)
|
|
Regional Oncology Research Center
|
3P30CA006973-48S1
|
$100,000
|
$1,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-48S2
|
$47,307
|
$473
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-48
|
$7,708,192
|
$77,082
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiologial Physics Center
|
5U10CA010953-42
|
$2,462,413
|
$49,248
|
Followill, David
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
5U10CA029511-31
|
$1,844,678
|
$36,894
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-03
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
1R01CA134794-01A2
|
$393,145
|
$98,286
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$523,283
|
$418,626
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
Total relevant funding to Neuroblastoma for this search: $20,050,819
|